{"pmid":32252139,"title":"Epidemiology and Clinical Features of Coronavirus disease 2019 in Children.","text":["Epidemiology and Clinical Features of Coronavirus disease 2019 in Children.","Coronavirus disease-2019 (COVID-19), which started in Wuhan, China, in December 2019 and has been declared a worldwide pandemic in March 11, 2020, is a novel infectious disease that causes respiratory illness and death. Pediatric COVID-19 accounts for a small percentage of patients with outbreaks and is often milder than adults, but can progress to severe disease in some cases. Even neonates can suffer from COVID-19, and children may play a role as a spreader in the community. In this review, we summarize what is known about COVID-19 in children and adolescents until now.","Clin Exp Pediatr","Choi, Soo-Han","Kim, Han Wool","Kang, Ji-Man","Kim, Dong Hyun","Cho, Eun Young","32252139"],"abstract":["Coronavirus disease-2019 (COVID-19), which started in Wuhan, China, in December 2019 and has been declared a worldwide pandemic in March 11, 2020, is a novel infectious disease that causes respiratory illness and death. Pediatric COVID-19 accounts for a small percentage of patients with outbreaks and is often milder than adults, but can progress to severe disease in some cases. Even neonates can suffer from COVID-19, and children may play a role as a spreader in the community. In this review, we summarize what is known about COVID-19 in children and adolescents until now."],"journal":"Clin Exp Pediatr","authors":["Choi, Soo-Han","Kim, Han Wool","Kang, Ji-Man","Kim, Dong Hyun","Cho, Eun Young"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32252139","week":"202015|Apr 06 - Apr 12","doi":"10.3345/cep.2020.00535","keywords":["COVID-19","Coronavirus","Newborn","child","infant"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1663352136200617984,"score":7.6679378,"similar":[{"pmid":32202343,"title":"Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.","text":["Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.","AIM: The coronavirus disease 2019 (COVID-19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognoses in children are rare. METHODS: A systematic literature review was carried out to identify papers on COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using the Medline and EMBASE databases between 1 January and 18 March 2020. RESULTS: The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1-5% of diagnosed COVID-19 cases, they often have milder disease than adults and deaths have been extremely rare. Diagnostic findings have been similar to adults, with fever and respiratory symptoms being prevalent, but fewer children seem to have developed severe pneumonia. Elevated inflammatory markers were less common in children and lymphocytopenia seemed rare. Newborn infants have developed symptomatic COVID-19, but evidence of vertical intrauterine transmission was scarce. Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances. CONCLUSIONS: COVID-19 has occurred in children, but they seemed to have a milder disease course and better prognoses than adults. Deaths were extremely rare.","Acta Paediatr","Ludvigsson, Jonas F","32202343"],"abstract":["AIM: The coronavirus disease 2019 (COVID-19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognoses in children are rare. METHODS: A systematic literature review was carried out to identify papers on COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using the Medline and EMBASE databases between 1 January and 18 March 2020. RESULTS: The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1-5% of diagnosed COVID-19 cases, they often have milder disease than adults and deaths have been extremely rare. Diagnostic findings have been similar to adults, with fever and respiratory symptoms being prevalent, but fewer children seem to have developed severe pneumonia. Elevated inflammatory markers were less common in children and lymphocytopenia seemed rare. Newborn infants have developed symptomatic COVID-19, but evidence of vertical intrauterine transmission was scarce. Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances. CONCLUSIONS: COVID-19 has occurred in children, but they seemed to have a milder disease course and better prognoses than adults. Deaths were extremely rare."],"journal":"Acta Paediatr","authors":["Ludvigsson, Jonas F"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32202343","week":"202013|Mar 23 - Mar 29","doi":"10.1111/apa.15270","keywords":["2019-nCoV","COVID-19","Children","Coronavirus","Newborn","SARS-CoV2"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1663352133639995393,"score":166.90375},{"pmid":32115733,"title":"Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.","text":["Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cause china epidemics with high morbidity and mortality, the infection has been transmitted to other countries. About three neonates and more than 230 children cases are reported. The disease condition of the main children was mild. There is currently no evidence that SARS-CoV-2 can be transmitted transplacentally from mother to the newborn. The treatment strategy for children with Coronavirus disease (COVID-19) is based on adult experience. Thus far, no deaths have been reported in the pediatric age group. This review describes the current understanding of COVID-19 infection in newborns and children.","J Med Virol","Lu, Qi","Shi, Yuan","32115733"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cause china epidemics with high morbidity and mortality, the infection has been transmitted to other countries. About three neonates and more than 230 children cases are reported. The disease condition of the main children was mild. There is currently no evidence that SARS-CoV-2 can be transmitted transplacentally from mother to the newborn. The treatment strategy for children with Coronavirus disease (COVID-19) is based on adult experience. Thus far, no deaths have been reported in the pediatric age group. This review describes the current understanding of COVID-19 infection in newborns and children."],"journal":"J Med Virol","authors":["Lu, Qi","Shi, Yuan"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32115733","week":"202010|Mar 02 - Mar 08","doi":"10.1002/jmv.25740","source":"PubMed","locations":["china"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Transmission"],"weight":1,"_version_":1663352134345687040,"score":116.21214},{"pmid":32134205,"title":"Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.","text":["Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.","PURPOSE: To discuss the different characteristics of clinical, laboratory, and chest computed tomography (CT) in pediatric patients from adults with 2019 novel coronavirus (COVID-19) infection. METHODS: The clinical, laboratory, and chest CT features of 20 pediatric inpatients with COVID-19 infection confirmed by pharyngeal swab COVID-19 nucleic acid test were retrospectively analyzed during 23 January and 8 February 2020. The clinical and laboratory information was obtained from inpatient records. All the patients were undergone chest CT in our hospital. RESULTS: Thirteen pediatric patients (13/20, 65%) had an identified history of close contact with COVID-19 diagnosed family members. Fever (12/20, 60%) and cough (13/20, 65%) were the most common symptoms. For laboratory findings, procalcitonin elevation (16/20, 80%) should be pay attention to, which is not common in adults. Coinfection (8/20, 40%) is common in pediatric patients. A total of 6 patients presented with unilateral pulmonary lesions (6/20, 30%), 10 with bilateral pulmonary lesions (10/20, 50%), and 4 cases showed no abnormality on chest CT (4/20, 20%). Consolidation with surrounding halo sign was observed in 10 patients (10/20, 50%), ground-glass opacities were observed in 12 patients (12/20, 60%), fine mesh shadow was observed in 4 patients (4/20, 20%), and tiny nodules were observed in 3 patients (3/20, 15%). CONCLUSION: Procalcitonin elevation and consolidation with surrounding halo signs were common in pediatric patients which were different from adults. It is suggested that underlying coinfection may be more common in pediatrics, and the consolidation with surrounding halo sign which is considered as a typical sign in pediatric patients.","Pediatr Pulmonol","Xia, Wei","Shao, Jianbo","Guo, Yu","Peng, Xuehua","Li, Zhen","Hu, Daoyu","32134205"],"abstract":["PURPOSE: To discuss the different characteristics of clinical, laboratory, and chest computed tomography (CT) in pediatric patients from adults with 2019 novel coronavirus (COVID-19) infection. METHODS: The clinical, laboratory, and chest CT features of 20 pediatric inpatients with COVID-19 infection confirmed by pharyngeal swab COVID-19 nucleic acid test were retrospectively analyzed during 23 January and 8 February 2020. The clinical and laboratory information was obtained from inpatient records. All the patients were undergone chest CT in our hospital. RESULTS: Thirteen pediatric patients (13/20, 65%) had an identified history of close contact with COVID-19 diagnosed family members. Fever (12/20, 60%) and cough (13/20, 65%) were the most common symptoms. For laboratory findings, procalcitonin elevation (16/20, 80%) should be pay attention to, which is not common in adults. Coinfection (8/20, 40%) is common in pediatric patients. A total of 6 patients presented with unilateral pulmonary lesions (6/20, 30%), 10 with bilateral pulmonary lesions (10/20, 50%), and 4 cases showed no abnormality on chest CT (4/20, 20%). Consolidation with surrounding halo sign was observed in 10 patients (10/20, 50%), ground-glass opacities were observed in 12 patients (12/20, 60%), fine mesh shadow was observed in 4 patients (4/20, 20%), and tiny nodules were observed in 3 patients (3/20, 15%). CONCLUSION: Procalcitonin elevation and consolidation with surrounding halo signs were common in pediatric patients which were different from adults. It is suggested that underlying coinfection may be more common in pediatrics, and the consolidation with surrounding halo sign which is considered as a typical sign in pediatric patients."],"journal":"Pediatr Pulmonol","authors":["Xia, Wei","Shao, Jianbo","Guo, Yu","Peng, Xuehua","Li, Zhen","Hu, Daoyu"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32134205","week":"202010|Mar 02 - Mar 08","doi":"10.1002/ppul.24718","keywords":["COVID-19","child","clinical features","infection","tomography"],"source":"PubMed","topics":["Transmission","Diagnosis"],"weight":1,"_version_":1663352134218809344,"score":114.29454},{"pmid":32252141,"title":"Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).","text":["Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).","A cluster of severe pneumonia of unknown etiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was isolated from lower respiratory tract sample as the causative agent. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 rapidly spread into at least 114 countries and killed more than 4,000 people by March 11 2020. WHO officially declared COVID-19 a pandemic on March 11, 2020. There have been two novel coronavirus outbreaks in the past two decades. The 2002-2003 outbreak of severe acute respiratory syndrome (SARS) in 2002-2003 caused by SARS-CoV had a case fatality rate of around 10% (8,098 confirmed cases and 774 death), while Middle East respiratory syndrome (MERS) caused by MERS-CoV killed 861 people out of a total 2,502 confirmed cases between 2012 and 2019. The purpose of this review is to summarize known-to-date information about SARS-CoV-2, transmission of SARS-CoV-2, and clinical features.","Clin Exp Pediatr","Park, Su Eun","32252141"],"abstract":["A cluster of severe pneumonia of unknown etiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was isolated from lower respiratory tract sample as the causative agent. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 rapidly spread into at least 114 countries and killed more than 4,000 people by March 11 2020. WHO officially declared COVID-19 a pandemic on March 11, 2020. There have been two novel coronavirus outbreaks in the past two decades. The 2002-2003 outbreak of severe acute respiratory syndrome (SARS) in 2002-2003 caused by SARS-CoV had a case fatality rate of around 10% (8,098 confirmed cases and 774 death), while Middle East respiratory syndrome (MERS) caused by MERS-CoV killed 861 people out of a total 2,502 confirmed cases between 2012 and 2019. The purpose of this review is to summarize known-to-date information about SARS-CoV-2, transmission of SARS-CoV-2, and clinical features."],"journal":"Clin Exp Pediatr","authors":["Park, Su Eun"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32252141","week":"202015|Apr 06 - Apr 12","doi":"10.3345/cep.2020.00493","keywords":["COVID-19","MERS-CoV","SARS-CoV","SARS-CoV-2","coronavirus"],"source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Diagnosis"],"weight":1,"_version_":1663352136196423680,"score":111.85148},{"pmid":32207032,"title":"Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China.","text":["Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China.","Since December 2019, COVID-19 has occurred unexpectedly and emerged as a health problem worldwide. Despite the rapidly increasing number of cases in subsequent weeks, the clinical characteristics of pediatric cases are rarely described. A cross-sectional multicenter study was carried out in 10 hospitals across Hubei province. A total of 25 confirmed pediatric cases of COVID-19 were collected. The demographic data, epidemiological history, underlying diseases, clinical manifestations, laboratory and radiological data, treatments, and outcomes were analyzed. Of 25 hospitalized patients with COVID-19, the boy to girl ratio was 1.27:1. The median age was 3 years. COVID-19 cases in children aged <3 years, 3.6 years, and >/=6-years patients were 10 (40%), 6 (24%), and 9 (36%), respectively. The most common symptoms at onset of illness were fever (13 [52%]), and dry cough (11 [44%]). Chest CT images showed essential normal in 8 cases (33.3%), unilateral involvement of lungs in 5 cases (20.8%), and bilateral involvement in 11 cases (45.8%). Clinical diagnoses included upper respiratory tract infection (n=8), mild pneumonia (n=15), and critical cases (n=2). Two critical cases (8%) were given invasive mechanical ventilation, corticosteroids, and immunoglobulin. The symptoms in 24 (96%) of 25 patients were alleviated and one patient had been discharged. It was concluded that children were susceptible to COVID-19 like adults, while the clinical presentations and outcomes were more favorable in children. However, children less than 3 years old accounted for majority cases and critical cases lied in this age group, which demanded extra attentions during home caring and hospitalization treatment.","Curr Med Sci","Zheng, Fang","Liao, Chun","Fan, Qi-Hong","Chen, Hong-Bo","Zhao, Xue-Gong","Xie, Zhong-Guo","Li, Xi-Lin","Chen, Chun-Xi","Lu, Xiao-Xia","Liu, Zhi-Sheng","Lu, Wei","Chen, Chun-Bao","Jiao, Rong","Zhang, Ai-Ming","Wang, Jin-Tang","Ding, Xi-Wei","Zeng, Yao-Guang","Cheng, Li-Ping","Huang, Qing-Feng","Wu, Jiang","Luo, Xi-Chang","Wang, Zhu-Jun","Zhong, Yan-Yan","Bai, Yan","Wu, Xiao-Yan","Jin, Run-Ming","32207032"],"abstract":["Since December 2019, COVID-19 has occurred unexpectedly and emerged as a health problem worldwide. Despite the rapidly increasing number of cases in subsequent weeks, the clinical characteristics of pediatric cases are rarely described. A cross-sectional multicenter study was carried out in 10 hospitals across Hubei province. A total of 25 confirmed pediatric cases of COVID-19 were collected. The demographic data, epidemiological history, underlying diseases, clinical manifestations, laboratory and radiological data, treatments, and outcomes were analyzed. Of 25 hospitalized patients with COVID-19, the boy to girl ratio was 1.27:1. The median age was 3 years. COVID-19 cases in children aged <3 years, 3.6 years, and >/=6-years patients were 10 (40%), 6 (24%), and 9 (36%), respectively. The most common symptoms at onset of illness were fever (13 [52%]), and dry cough (11 [44%]). Chest CT images showed essential normal in 8 cases (33.3%), unilateral involvement of lungs in 5 cases (20.8%), and bilateral involvement in 11 cases (45.8%). Clinical diagnoses included upper respiratory tract infection (n=8), mild pneumonia (n=15), and critical cases (n=2). Two critical cases (8%) were given invasive mechanical ventilation, corticosteroids, and immunoglobulin. The symptoms in 24 (96%) of 25 patients were alleviated and one patient had been discharged. It was concluded that children were susceptible to COVID-19 like adults, while the clinical presentations and outcomes were more favorable in children. However, children less than 3 years old accounted for majority cases and critical cases lied in this age group, which demanded extra attentions during home caring and hospitalization treatment."],"journal":"Curr Med Sci","authors":["Zheng, Fang","Liao, Chun","Fan, Qi-Hong","Chen, Hong-Bo","Zhao, Xue-Gong","Xie, Zhong-Guo","Li, Xi-Lin","Chen, Chun-Xi","Lu, Xiao-Xia","Liu, Zhi-Sheng","Lu, Wei","Chen, Chun-Bao","Jiao, Rong","Zhang, Ai-Ming","Wang, Jin-Tang","Ding, Xi-Wei","Zeng, Yao-Guang","Cheng, Li-Ping","Huang, Qing-Feng","Wu, Jiang","Luo, Xi-Chang","Wang, Zhu-Jun","Zhong, Yan-Yan","Bai, Yan","Wu, Xiao-Yan","Jin, Run-Ming"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32207032","week":"202013|Mar 23 - Mar 29","doi":"10.1007/s11596-020-2172-6","keywords":["COVID-19","SARS-CoV-2","children","coronavirus"],"source":"PubMed","locations":["China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1663352133717590016,"score":109.91761}]}